In Brief
A pharmaceutical firm was prosecuted for failing to maintain manufacturing records as required by law during production of a regulated drug (Pseudoephedrine). The company challenged the trial court's decision to send the case to a Special Court, arguing it should be tried by a lower court. The Supreme Court upheld the trial court's decision, finding that the alleged violations of record-keeping requirements, when linked to drug manufacture and distribution, constitute a more serious offence triable only by higher courts with a three-year time limit—not the one-year limit the company claimed. The complaint was filed within the prescribed timeframe, and the Court confirmed the correct forum for trial.
The lawyer headnote and full judgment text are available to registered users.